ArticleEndocrinology2013

MK-2206, an AKT inhibitor, promotes caspase-independent cell death and inhibits leiomyoma growth.

Elizabeth C Sefton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.